chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID-19) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, the patient experienced COVID-19 (COVID-19). At the time of the report, COVID-19 (COVID-19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 18-Mar-2021, SARS-CoV-2 test positive: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant Medication was reported. treatment Medication was notreported.
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Nausea, Somnolence
Clinical narrative: Sleepy; Fatigued; Headache; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (Sleepy), FATIGUE (Fatigued), HEADACHE (Headache) and NAUSEA (Nausea) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.  On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 20-Mar-2021, the patient experienced SOMNOLENCE (Sleepy), FATIGUE (Fatigued), HEADACHE (Headache) and NAUSEA (Nausea). At the time of the report, SOMNOLENCE (Sleepy), FATIGUE (Fatigued), HEADACHE (Headache) and NAUSEA (Nausea) had not resolved.  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.  Concomitant medication and treatment details were not provided.
Sex: F
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: Body ache; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Body ache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MYALGIA (Body ache). At the time of the report, MYALGIA (Body ache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use were not provided by the reporter.  Treatment medication was not provided.   Reporter did not allow further contact
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Blister, Herpes zoster
Clinical narrative: Broke out with blisters; Shingles; Pain in her back; This spontaneous case was reported by a patient and describes the occurrence of BACK PAIN (Pain in her back), BLISTER (Broke out with blisters) and HERPES ZOSTER (Shingles) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced BACK PAIN (Pain in her back). On 16-Mar-2021, the patient experienced BLISTER (Broke out with blisters) and HERPES ZOSTER (Shingles). The patient was treated with PREDNISONE at an unspecified dose and frequency; TRAMADOL at an unspecified dose and frequency and CALAMINE, GLYCEROL, ZINC OXIDE (CALAMINE LOTION) at an unspecified dose and frequency. At the time of the report, BACK PAIN (Pain in her back), BLISTER (Broke out with blisters) and HERPES ZOSTER (Shingles) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       On 19-Mar-2021, she went to a walk-in clinic and received an unspecified injection and was prescribed Prednisone and Tramadol. She also applied Calamine lotion. She continues to have blisters however they have stopped spreading.  The patient was taking medicine for blood pressure.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Dyspnoea, Headache
Clinical narrative: Sensation of something getting stuck in the chest; Headache; Labored Breathing; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Labored Breathing), CHEST DISCOMFORT (Sensation of something getting stuck in the chest) and HEADACHE (Headache) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concurrent medical conditions included No adverse event.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, the patient experienced DYSPNOEA (Labored Breathing) and HEADACHE (Headache). On 12-Mar-2021, the patient experienced CHEST DISCOMFORT (Sensation of something getting stuck in the chest). At the time of the report, DYSPNOEA (Labored Breathing), CHEST DISCOMFORT (Sensation of something getting stuck in the chest) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication list was not provided. Treatment information was not provided.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia, Vomiting
Clinical narrative: Vomiting; Fever 101.6F; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever 101.6F) and VOMITING (Vomiting) in a 41-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced PYREXIA (Fever 101.6F). On 21-Mar-2021, the patient experienced VOMITING (Vomiting). At the time of the report, PYREXIA (Fever 101.6F) and VOMITING (Vomiting) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101.6 f (High) 101.6 F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported No treatment drugs were reported Statements
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pyrexia, Urinary tract infection
Clinical narrative: UTI; Body aches; Fever; This spontaneous case was reported by a consumer and describes the occurrence of URINARY TRACT INFECTION (UTI), MYALGIA (Body aches) and PYREXIA (Fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 19-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Mar-2021, the patient experienced URINARY TRACT INFECTION (UTI), MYALGIA (Body aches) and PYREXIA (Fever). At the time of the report, URINARY TRACT INFECTION (UTI), MYALGIA (Body aches) and PYREXIA (Fever) outcome was unknown.            No concomitant medications were provided.  Treatment medications were unknown.  The patient received both scheduled doses of mRNA-1273 prior to the events; therefore, action taken with the drug in response to the events are not applicable.   This case was linked to MOD-2021-053107 (Patient Link).   Reporter did not allow further contact
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Shingles; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (Shingles) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, the patient experienced HERPES ZOSTER (Shingles). At the time of the report, HERPES ZOSTER (Shingles) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information was not provided concomitant medication were not provided
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: got one dose and hasn't gotten second dose, past 42 days; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (got one dose and hasn't gotten second dose, past 42 days) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Jan-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (got one dose and hasn't gotten second dose, past 42 days). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (got one dose and hasn't gotten second dose, past 42 days) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.  Treatment information was not provided.; Sender's Comments: This report refers to a case of Inappropriate Schedule Of Product Administration for mRNA-1273 (Lot number: 007M20A) with no associated AEs.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Illness, Pyrexia, Vomiting
Clinical narrative: Chills; Fever; Headache; Sick; Vomited; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Sick), HEADACHE (Headache), CHILLS (Chills), PYREXIA (Fever) and VOMITING (Vomited) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008B212A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in December 2020.    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Mar-2021, the patient experienced ILLNESS (Sick) and VOMITING (Vomited). On 21-Mar-2021 at 3:00 AM, the patient experienced HEADACHE (Headache). On 21-Mar-2021 at 10:00 AM, the patient experienced CHILLS (Chills) and PYREXIA (Fever). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 21-Mar-2021, ILLNESS (Sick) and VOMITING (Vomited) had resolved. On 21-Mar-2021 at 1:00 PM, CHILLS (Chills) and PYREXIA (Fever) had resolved. On 22-Mar-2021, HEADACHE (Headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications included unspecified Statins for cholesterol.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Vaccination site erythema
Clinical narrative: Redover elbow of arm of injection site; itching; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itching) and VACCINATION SITE ERYTHEMA (Redover elbow of arm of injection site) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced PRURITUS (itching). On 17-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA (Redover elbow of arm of injection site). At the time of the report, PRURITUS (itching) and VACCINATION SITE ERYTHEMA (Redover elbow of arm of injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment medications were reported.
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Vaccination site pain
Clinical narrative: Swollen arm; injection site pain; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swollen arm) and VACCINATION SITE PAIN (injection site pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1. On an unknown date, the patient experienced PERIPHERAL SWELLING (Swollen arm) and VACCINATION SITE PAIN (injection site pain). At the time of the report, PERIPHERAL SWELLING (Swollen arm) and VACCINATION SITE PAIN (injection site pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The concomitant medications and treatment details were not provided.
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Feeling abnormal, SARS-CoV-2 test
Clinical narrative: COVID-19; Feeling bad; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID-19) and FEELING ABNORMAL (Feeling bad) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (COVID-19) and FEELING ABNORMAL (Feeling bad). At the time of the report, COVID-19 (COVID-19) and FEELING ABNORMAL (Feeling bad) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive (Positive) Positive.    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.    The patient had body aches, headaches, tired, feeling bad, no smell which are included as the COVID-19 symptoms.  Concomitant medication information was not reported  No treatment information was reported.   Most recent FOLLOW-UP information incorporated above includes: On 23-Jul-2021: Updated reporter's address
Sex: F
Vaccine: COVID19
Symptoms: Feeding disorder, Headache, Insomnia, Malaise, Nausea
Clinical narrative: Fever; Constant headache; Nauseous; Cannot sleep; Cannot eat or drink anything cannot eat or drink anything only little sips of water; Very very sick; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (Cannot sleep), FEEDING DISORDER (Cannot eat or drink anything cannot eat or drink anything only little sips of water), MALAISE (Very very sick), PYREXIA (Fever) and HEADACHE (Constant headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Migraine.   On 19-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Mar-2021, the patient experienced INSOMNIA (Cannot sleep), FEEDING DISORDER (Cannot eat or drink anything cannot eat or drink anything only little sips of water), HEADACHE (Constant headache) and NAUSEA (Nauseous). 19-Mar-2021, the patient experienced MALAISE (Very very sick). On 20-Mar-2021, the patient experienced PYREXIA (Fever). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] at an unspecified dose and frequency; IBUPROFEN at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 20-Mar-2021, PYREXIA (Fever) had resolved. At the time of the report, INSOMNIA (Cannot sleep), FEEDING DISORDER (Cannot eat or drink anything cannot eat or drink anything only little sips of water), MALAISE (Very very sick), HEADACHE (Constant headache) and NAUSEA (Nauseous) outcome was unknown.            Patient had Ice for treatment along with the treatment medication. No concomitant product was reported.   Most recent FOLLOW-UP information incorporated above includes: On 05-Aug-2021: Non-Significant follow-up received and reporter details were added.
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Fever; Constant headache; Nauseous; Cannot sleep; Cannot eat or drink anything cannot eat or drink anything only little sips of water; Very very sick; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (Cannot sleep), FEEDING DISORDER (Cannot eat or drink anything cannot eat or drink anything only little sips of water), MALAISE (Very very sick), PYREXIA (Fever) and HEADACHE (Constant headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Migraine.   On 19-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Mar-2021, the patient experienced INSOMNIA (Cannot sleep), FEEDING DISORDER (Cannot eat or drink anything cannot eat or drink anything only little sips of water), HEADACHE (Constant headache) and NAUSEA (Nauseous). 19-Mar-2021, the patient experienced MALAISE (Very very sick). On 20-Mar-2021, the patient experienced PYREXIA (Fever). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] at an unspecified dose and frequency; IBUPROFEN at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 20-Mar-2021, PYREXIA (Fever) had resolved. At the time of the report, INSOMNIA (Cannot sleep), FEEDING DISORDER (Cannot eat or drink anything cannot eat or drink anything only little sips of water), MALAISE (Very very sick), HEADACHE (Constant headache) and NAUSEA (Nauseous) outcome was unknown.            Patient had Ice for treatment along with the treatment medication. No concomitant product was reported.   Most recent FOLLOW-UP information incorporated above includes: On 05-Aug-2021: Non-Significant follow-up received and reporter details were added.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Musculoskeletal stiffness, Vaccination site pain
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (Stiffness in legs) and VACCINATION SITE PAIN (Injection site pain) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination. No Medical History information was reported. On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (Stiffness in legs) and VACCINATION SITE PAIN (Injection site pain). At the time of the report, MUSCULOSKELETAL STIFFNESS (Stiffness in legs) and VACCINATION SITE PAIN (Injection site pain) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medication use was not provided. Treatment information included was not provided.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Blood glucose abnormal, Lethargy, Paraesthesia, Vaccination site pain, Vaccination site swelling
Clinical narrative: arm swelled up; sensitive to touch; extremely sore; lethargic; blood sugar not in control; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of LETHARGY (lethargic), PARAESTHESIA (sensitive to touch), BLOOD GLUCOSE ABNORMAL (blood sugar not in control), VACCINATION SITE PAIN (extremely sore) and VACCINATION SITE SWELLING (arm swelled up) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On 15-Mar-2021, the patient experienced LETHARGY (lethargic) and BLOOD GLUCOSE ABNORMAL (blood sugar not in control). On 19-Mar-2021, the patient experienced PARAESTHESIA (sensitive to touch) and VACCINATION SITE PAIN (extremely sore). On an unknown date, the patient experienced VACCINATION SITE SWELLING (arm swelled up). At the time of the report, LETHARGY (lethargic), PARAESTHESIA (sensitive to touch), BLOOD GLUCOSE ABNORMAL (blood sugar not in control), VACCINATION SITE PAIN (extremely sore) and VACCINATION SITE SWELLING (arm swelled up) outcome was unknown. Not Provided          patient applied ice using Tylenol and Benadryl.   Reporter did not allow further contact
Age: 93.0
Sex: F
Vaccine: COVID19
Symptoms: Muscle spasms
Clinical narrative: solid cramps on both her legs to the point of not being able to walk; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (solid cramps on both her legs to the point of not being able to walk) in a 93-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 27-Feb-2021, the patient experienced MUSCLE SPASMS (solid cramps on both her legs to the point of not being able to walk). At the time of the report, MUSCLE SPASMS (solid cramps on both her legs to the point of not being able to walk) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Possible partial first dose of 0.3 mL; This spontaneous case was reported by a consumer and describes the occurrence of INCORRECT DOSE ADMINISTERED (Possible partial first dose of 0.3 mL) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 immunisation.     No Medical History information was reported.    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .3 ml. On 19-Mar-2021, the patient experienced INCORRECT DOSE ADMINISTERED (Possible partial first dose of 0.3 mL). On 19-Mar-2021, INCORRECT DOSE ADMINISTERED (Possible partial first dose of 0.3 mL) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication and treatment drug were not reported.   This case was linked to MOD21-059986 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 22-Mar-2021: No adverse event deleted as relevant medical history. Lower level term updated from Accidental underdose to Inappropriate dose of vaccine administered.; Sender's Comments:  MOD21-059986:cross-linked case
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered at inappropriate site
Clinical narrative: Incorrect site of injection; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT ADMINISTERED AT INAPPROPRIATE SITE (Incorrect site of injection) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Mar-2021, the patient experienced PRODUCT ADMINISTERED AT INAPPROPRIATE SITE (Incorrect site of injection). At the time of the report, PRODUCT ADMINISTERED AT INAPPROPRIATE SITE (Incorrect site of injection) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant information was reported.  No treatment information was provided.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Energy increased, Euphoric mood, Vaccination site pain
Clinical narrative: Euphoria; Some soreness at injection site; Excess amount of energy; Excessive energy has slowly decreased.; This spontaneous case was reported by a consumer and describes the occurrence of ENERGY INCREASED (Excess amount of energy), ASTHENIA (Excessive energy has slowly decreased.), EUPHORIC MOOD (Euphoria) and VACCINATION SITE PAIN (Some soreness at injection site) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008AMA) for COVID-19 vaccination.     Concurrent medical conditions included Polycystic ovarian syndrome (No recent changes occurred in the status of chronic condition) since 06-Jan-2003. Concomitant products included TRAZODONE, METFORMIN HYDROCHLORIDE (METFORMIN ER) and ETHINYLESTRADIOL, FERROUS FUMARATE, NORETHISTERONE ACETATE (JUNEL FE) for an unknown indication.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced ENERGY INCREASED (Excess amount of energy), ASTHENIA (Excessive energy has slowly decreased.) and VACCINATION SITE PAIN (Some soreness at injection site). On an unknown date, the patient experienced EUPHORIC MOOD (Euphoria). On 23-Mar-2021, ENERGY INCREASED (Excess amount of energy) had resolved. At the time of the report, ASTHENIA (Excessive energy has slowly decreased.), EUPHORIC MOOD (Euphoria) and VACCINATION SITE PAIN (Some soreness at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information were reported.Patient's heart rate stayed normal as did blood pressure and no insomnia experienced.   Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021: Follow-up information received on 10 May 2021.Added patient demographics, medical history,concomitant medication's dosage details and new event. Updated outcome of event, excess energy from unknown to resolved,updated re-challenge and de-challenge.
Sex: F
Vaccine: COVID19
Symptoms: Heart rate, Heart rate increased, Malaise
Clinical narrative: felt sick after opening the bleach; rapid heartbeat/Fast heart rate feels different than her a-fib; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (rapid heartbeat), HEART RATE INCREASED (Fast heart rate feels different than her a-fib) and ALLERGY TO CHEMICALS (thinks she now has allergies to bleach) in an 82-year-old female elderly exposed to mRNA-1273 (Moderna COVID-19 Vaccine) , while the parent received the product for COVID-19 vaccination.     No Medical History information was reported.    On 24-Feb-2021, the parent received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 2. Last menstrual period and estimated date of delivery were not provided. On 27-Feb-2021, the elderly was diagnosed with HEART RATE INCREASED (rapid heartbeat). 27-Feb-2021, the elderly experienced HEART RATE INCREASED (Fast heart rate feels different than her a-fib). On 15-Mar-2021, the elderly was diagnosed with ALLERGY TO CHEMICALS (thinks she now has allergies to bleach). The Elderly was exposed to mRNA-1273 (Moderna COVID-19 Vaccine) during pregnancy.  Not Provided          Treatment Medications include natural supplements to thin out blood,  concomitant medicines were not included   Action taken with mRNA-1273 in response to the event was not applicable.   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Chills, Lymphadenopathy, Nasopharyngitis, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: colds; on and off fever; chills; swollen lymph nodes; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (colds), LYMPHADENOPATHY (swollen lymph nodes), PYREXIA (on and off fever) and CHILLS (chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, the patient experienced LYMPHADENOPATHY (swollen lymph nodes). On 12-Mar-2021, the patient experienced NASOPHARYNGITIS (colds), PYREXIA (on and off fever) and CHILLS (chills). At the time of the report, NASOPHARYNGITIS (colds), LYMPHADENOPATHY (swollen lymph nodes), PYREXIA (on and off fever) and CHILLS (chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-Mar-2021, SARS-CoV-2 test positive: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Heart rate increased, Swelling
Clinical narrative: This spontaneous case was reported by a patient and describes the occurrence of HEART RATE INCREASED (fast heart rate), DYSPNOEA (difficulty breathing) and SWELLING (swelling of her face and throat) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunisation.  No Medical History information was reported. On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form(s). On an unknown date, the patient experienced HEART RATE INCREASED (fast heart rate), DYSPNOEA (difficulty breathing) and SWELLING (swelling of her face and throat). At the time of the report, HEART RATE INCREASED (fast heart rate), DYSPNOEA (difficulty breathing) and SWELLING (swelling of her face and throat) outcome was unknown. Not Provided. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No  concomitant medical  provided by the reporter. No treatment medication provided by the reporter.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Joint range of motion decreased, Limb discomfort, Movement disorder, Pain
Clinical narrative: can not raise his shoulder/his shoulder locks right up on him; can not tie his shoe; ache/couldn't sleep on his left side; couldn't raise his hand above his head; This spontaneous case was reported by an other health care professional and describes the occurrence of PAIN (ache/couldn't sleep on his left side), LIMB DISCOMFORT (couldn't raise his hand above his head), JOINT RANGE OF MOTION DECREASED (can not raise his shoulder/his shoulder locks right up on him) and MOVEMENT DISORDER (can not tie his shoe) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included GLIMEPIRIDE, TAMSULOSIN, LISINOPRIL, METOPROLOL and ASPIRIN [ACETYLSALICYLIC ACID] for an unknown indication.    On 21-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Mar-2021, the patient experienced PAIN (ache/couldn't sleep on his left side) and LIMB DISCOMFORT (couldn't raise his hand above his head). On 22-Mar-2021, the patient experienced JOINT RANGE OF MOTION DECREASED (can not raise his shoulder/his shoulder locks right up on him) and MOVEMENT DISORDER (can not tie his shoe). At the time of the report, PAIN (ache/couldn't sleep on his left side), LIMB DISCOMFORT (couldn't raise his hand above his head), JOINT RANGE OF MOTION DECREASED (can not raise his shoulder/his shoulder locks right up on him) and MOVEMENT DISORDER (can not tie his shoe) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment information was not provided. Lab details were not provided.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Headache, Myalgia
Clinical narrative: headache; dizzy; muscle pain; chills; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizzy), MYALGIA (muscle pain), CHILLS (chills) and HEADACHE (headache) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     Concomitant products included SITAGLIPTIN (JANUVIA [SITAGLIPTIN]), ROSUVASTATIN and HYDROCHLOROTHIAZIDE for an unknown indication.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 20-Mar-2021, the patient experienced DIZZINESS (dizzy), MYALGIA (muscle pain) and CHILLS (chills). On 22-Mar-2021, the patient experienced HEADACHE (headache). The patient was treated with MECLIZINE HYDROCHLORIDE ongoing since an unknown date at a dose of UNK dosage form and PARACETAMOL (TYLENOL) ongoing since an unknown date at a dose of UNK dosage form. At the time of the report, DIZZINESS (dizzy), MYALGIA (muscle pain) and CHILLS (chills) had not resolved and HEADACHE (headache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment details not provided.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: patient has not received second dose of Moderna Covid-19 vaccine; A spontaneous report was received from a healthcare facility staff member concerning her husband, a 71-year-old male patient who received Moderna (mRNA-1273) vaccine and has not received second dose of Moderna Covid-19 vaccine/Product dose omission issue.   The patient's medical history was not provided. Products known to have been used by the patient, within two weeks prior to the event, included lisinopril, simvastatin, acetylsalicylic acid, omeprazole, and metoprolol for unknown indications.  On 6 Jan 2021, prior to the onset of the symptoms, the patient received their first of two planned doses of mRNA-1273 (Batch number: unknown) intramuscularly in the right arm for prophylaxis of COVID-19 infection.  At the time of this report, the patient has not received the second dose of Moderna Covid-19 vaccine.  Treatment information was unknown.  Action taken with mRNA-1273 in response to the event(s) was not reported.  The outcome of the event, not received second dose of Moderna Covid-19 vaccine was resolved at the time of this report.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site induration
Clinical narrative: injection site puffy; injection site arm red; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE INDURATION (injection site puffy) and VACCINATION SITE ERYTHEMA (injection site arm red) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038A21A and 023M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 17-Mar-2021, the patient experienced VACCINATION SITE INDURATION (injection site puffy) and VACCINATION SITE ERYTHEMA (injection site arm red). At the time of the report, VACCINATION SITE INDURATION (injection site puffy) and VACCINATION SITE ERYTHEMA (injection site arm red) outcome was unknown.            No concomitant medication was reported No treatment medication was reported Action taken with the mRNA-1273 vaccine in response to the events was not applicable
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Myalgia, Nervousness, Pain in extremity, Vaccination site erythema
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (felt like my arm hurt and arm soreness), NERVOUSNESS (little edgy and nervous last night), VACCINATION SITE RASH (injection site rash and redness and itching), VACCINATION SITE ERYTHEMA (injection site rash and redness and itching) and VACCINATION SITE PRURITUS (injection site rash and redness and itching) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was Provided by the reporter.  Concomitant products included ATORVASTATIN, LOSARTAN POTASSIUM, VITAMINS NOS (MTV), CALCIUM, CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000), ASCORBIC ACID, ROSA CANINA FRUIT (VITAMIN C & ROSEHIP), AZELASTINE HYDROCHLORIDE (ASTEPRO) and OMEPRAZOLE (PRILOSEC [OMEPRAZOLE]) for an unknown indication.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Mar-2021, the patient experienced PAIN IN EXTREMITY (felt like my arm hurt and arm soreness). On 21-Mar-2021, the patient experienced NERVOUSNESS (little edgy and nervous last night), VACCINATION SITE RASH (injection site rash and redness and itching), VACCINATION SITE ERYTHEMA (injection site rash and redness and itching) and VACCINATION SITE PRURITUS (injection site rash and redness and itching). On an unknown date, the patient experienced MYALGIA (achiness) and FATIGUE (fatigue, described as feeling weak). At the time of the report, PAIN IN EXTREMITY (felt like my arm hurt and arm soreness), NERVOUSNESS (little edgy and nervous last night), VACCINATION SITE RASH (injection site rash and redness and itching), VACCINATION SITE ERYTHEMA (injection site rash and redness and itching), VACCINATION SITE PRURITUS (injection site rash and redness and itching), MYALGIA (achiness) and FATIGUE (fatigue, described as feeling weak) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medications were reported.  Follow-up received on 04-JUN-2021 date included no new information.   Most recent FOLLOW-UP information incorporated above includes: On 02-May-2021: Follow up received on 02-may-2021: Second dose vaccine details and events updated(created separate case for dose two) On 04-Jun-2021: Follow up received: 4 Jun 2021 No significant information updated
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site rash
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (felt like my arm hurt and arm soreness), NERVOUSNESS (little edgy and nervous last night), VACCINATION SITE RASH (injection site rash and redness and itching), VACCINATION SITE ERYTHEMA (injection site rash and redness and itching) and VACCINATION SITE PRURITUS (injection site rash and redness and itching) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was Provided by the reporter.  Concomitant products included ATORVASTATIN, LOSARTAN POTASSIUM, VITAMINS NOS (MTV), CALCIUM, CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000), ASCORBIC ACID, ROSA CANINA FRUIT (VITAMIN C & ROSEHIP), AZELASTINE HYDROCHLORIDE (ASTEPRO) and OMEPRAZOLE (PRILOSEC [OMEPRAZOLE]) for an unknown indication.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Mar-2021, the patient experienced PAIN IN EXTREMITY (felt like my arm hurt and arm soreness). On 21-Mar-2021, the patient experienced NERVOUSNESS (little edgy and nervous last night), VACCINATION SITE RASH (injection site rash and redness and itching), VACCINATION SITE ERYTHEMA (injection site rash and redness and itching) and VACCINATION SITE PRURITUS (injection site rash and redness and itching). On an unknown date, the patient experienced MYALGIA (achiness) and FATIGUE (fatigue, described as feeling weak). At the time of the report, PAIN IN EXTREMITY (felt like my arm hurt and arm soreness), NERVOUSNESS (little edgy and nervous last night), VACCINATION SITE RASH (injection site rash and redness and itching), VACCINATION SITE ERYTHEMA (injection site rash and redness and itching), VACCINATION SITE PRURITUS (injection site rash and redness and itching), MYALGIA (achiness) and FATIGUE (fatigue, described as feeling weak) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medications were reported.  Follow-up received on 04-JUN-2021 date included no new information.   Most recent FOLLOW-UP information incorporated above includes: On 02-May-2021: Follow up received on 02-may-2021: Second dose vaccine details and events updated(created separate case for dose two) On 04-Jun-2021: Follow up received: 4 Jun 2021 No significant information updated
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Vaccination site erythema, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: swelling on left arm from the elbow to the shoulder; Hot at injection site; itchy at injection site; red at injection site; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (swelling on left arm from the elbow to the shoulder), VACCINATION SITE WARMTH (Hot at injection site), VACCINATION SITE PRURITUS (itchy at injection site) and VACCINATION SITE ERYTHEMA (red at injection site) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 15-Mar-2021, the patient experienced PERIPHERAL SWELLING (swelling on left arm from the elbow to the shoulder), VACCINATION SITE WARMTH (Hot at injection site), VACCINATION SITE PRURITUS (itchy at injection site) and VACCINATION SITE ERYTHEMA (red at injection site). The patient was treated with FEXOFENADINE HYDROCHLORIDE (ALLEGRA) at an unspecified dose and frequency. On 22-Mar-2021, VACCINATION SITE ERYTHEMA (red at injection site) was resolving. At the time of the report, PERIPHERAL SWELLING (swelling on left arm from the elbow to the shoulder), VACCINATION SITE WARMTH (Hot at injection site) and VACCINATION SITE PRURITUS (itchy at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site erythema
Clinical narrative: Red circle (2-3 inches) at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Red circle (2-3 inches) at injection site) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA (Red circle (2-3 inches) at injection site). At the time of the report, VACCINATION SITE ERYTHEMA (Red circle (2-3 inches) at injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessment.  Concomitant product use was not provided by the reporter.  No treatment medication was reported.
Sex: F
Vaccine: COVID19
Symptoms: Cough
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Experiencing cough after receiving the Moderna vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COUGH (Experiencing cough after receiving the Moderna vaccine). At the time of the report, COUGH (Experiencing cough after receiving the Moderna vaccine) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 10-Aug-2021: Follow up received on 10-Aug-2021 and included No new information.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Heart rate increased
Clinical narrative: Rapid heart rate, immediately; Body warmed up immediately; This spontaneous case was reported by a health care professional and describes the occurrence of HEART RATE INCREASED (Rapid heart rate, immediately) and FEELING HOT (Body warmed up immediately) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A021A) for COVID-19 vaccination.     Concomitant products included VITAMIN D NOS and ASCORBIC ACID (VITAMIN C ACID) for an unknown indication.    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, the patient experienced HEART RATE INCREASED (Rapid heart rate, immediately) and FEELING HOT (Body warmed up immediately). At the time of the report, HEART RATE INCREASED (Rapid heart rate, immediately) and FEELING HOT (Body warmed up immediately) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication also includes Antihyperlipidemic and Eye drops
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Palpitations
Clinical narrative: heart started racing; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (heart started racing) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Mar-2021, the patient experienced PALPITATIONS (heart started racing). On 22-Mar-2021, PALPITATIONS (heart started racing) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Mar-2021, Blood pressure measurement: 131/77 (High) 131/77.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication reported   No treatment medication reported